Germany has restricted the use of AstraZeneca’s Covid-19 vaccine as a precautionary measure amid reports the jab is being linked to more cases of suspected adverse effects, some resulting in death.
The country’s Standing Vaccination Commission recommended on Tuesday that AstraZeneca’s Vaxzevria only be given to men and women over the age of 60, or in exceptional cases. The decision was made due to “available, albeit limited, evidence” concerning the drug’s safety.
The commission announced its recommendation hours after the city of Berlin introduced an identical policy. Earlier, two state-owned clinics in the city halted AstraZeneca shots for women under 55 years of age. Munich followed suit with its own rule banning the shot for people under 60.
Health Minister Jens Spahn was scheduled to speak with regional counterparts about the AstraZeneca drug later on Tuesday, a ministry spokesperson announced. Germany had suspended emergency use of the AstraZeneca shot earlier this month, but then lifted the temporary ban after EU regulators deemed it to be safe.
The latest restrictions placed on the drug come after Germany’s vaccine regulator, the Paul Ehrlich Institute, disclosed that as of March 29, the country has recorded 31 cases of cerebral sinus vein thrombosis (CSVT), nine of which resulted in death, after people were given the Vaxzevria injection. CSVT is a rare form of blood clot that forms in the brain.